Related Experiment Videos
[Hepatitis virus and hepatocellular carcinoma]
O Rosmorduc1, P Paterlini, R Poupon
1Service d'Hépato-Gastroenterologie, CHU Saint-Antoine, Paris.
Gastroenterologie Clinique Et Biologique
|June 29, 1999
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period.
Alimentary pharmacology & therapeutics·2017
Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
HCC and NASH: how strong is the clinical demonstration?
Clinics and research in hepatology and gastroenterology·2012
Antiangiogenic therapies in portal hypertension: a breakthrough in hepatology.
Gastroenterologie clinique et biologique·2010
[Treatment of chronic hepatitis B: adherence and safety].
Gastroenterologie clinique et biologique·2010
[Long-term therapy for chronic hepatitis B in HIV co-infected patients].
Gastroenterologie clinique et biologique·2010
[Analogs combination therapy in chronic hepatitis B: when and how?].
Gastroenterologie clinique et biologique·2010
[HBsAg seroclearance: prognostic value for the response to treatment and the long-term outcome].
Gastroenterologie clinique et biologique·2010
[HBsAg quantification: virological significance].
Gastroenterologie clinique et biologique·2010
[Influence of treatment on long-term evolution of chronic hepatitis B].
Gastroenterologie clinique et biologique·2010
US real-world biomarker testing differences and treatment choice in advanced ovarian cancer: results of a retrospective study.
Future oncology (London, England)·2026
Epitranscriptomic control of epithelial-mesenchymal transition in cancer: mechanisms, plasticity, and therapeutic opportunities.
Frontiers in cell and developmental biology·2026
A cross-validated deep learning framework for automated detection of DMBA-induced ovarian cancer from histopathological images with CA-125 biomarker support.
Frontiers in artificial intelligence·2026